CHM Cannabis
Home > Boards > US Listed > Medical - Equipment >


Add SPNC Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 6/13/2017 12:11:43 PM - Followers: 5 - Board type: Free - Posts Today: 0

Address 96 Talamine Court Colorado Springs, CO 80907 Contact Phone: 719-633-8333 Fax: 719-633-2248 Web site http://www.spectranetics.com Basics Sector: Healthcare Industry: Medical Appliances & Equipment Full Time Employees: 374 Profile The Spectranetics Corporation develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system using its excimer laser technology. The company's Excimer laser technology delivers relatively cool ultraviolet energy to remove arterial blockages, including plaque, calcium, and thrombus. It offers a range of proprietary laser devices designed for indications, including peripheral laser atherectomy in the upper and lower leg; and coronary laser atherectomy. The company's peripheral laser atherectomy products include TURBO Elite Catheters for peripheral laser atherectomy; TURBO-Booster for the TURBO elite laser catheters facilitating directed laser ablation of blockages in the main arteries at or above the knee; and Quick-Cross Support Catheter that supports catheters for use in the cardiovascular system to support and assist standard guidewires to facilitate initial crossing of the blockage. Its coronary laser atherectomy products comprise disposable catheters consisting of Rapid Exchange Catheter, Over-The-Wire Catheter, POINT 9 Catheter, and Quick-Cross Support Catheter. The Spectranetics Corporation also offers devices for the removal of infected, defective, or abandoned pacemaker and implantable cardiac defibrillators leads. The company's CVX-300 excimer laser unit includes Spectranetics Laser Sheath, a laser-assisted lead removal device; and Lead Locking Device, a mechanical device that assists in the removal of faulty leads by providing traction on the inner aspect of the leads, which are constructed of wire coils covered by insulating material. It operates in the United States, Canada, Mexico, South America, the Pacific Rim, and Australia. The Spectranetics Corporation was founded in 1984 and is based in Colorado Springs, Colorado. Management Mr. John G. Schulte, 59 Chief Exec. Officer, Pres Mr. Guy A. Childs, 42 Chief Financial Officer, Principal Accounting Officer, VP Mr. Will McGuire, 45 Chief Operating Officer Ms. Kelly W. Elliott RN MS, 46 VP of Clinical Affairs Mr. Stephen D. Okland Jr., 44 VP of Sales and Marketing for the United States Spectranetics Excimer laser system The Excimer laser system is the only multi-functional laser system available. Its utility has been proven in many cardiac and vascular applications. The ‘cool’ laser uses pulsed ultraviolet laser energy to accurately ablate tissue. The CVX-300 generator is compatible with a range of Spectranetics products, the use of which is determined by the procedure undertaken. Pacing lead extraction Laser assisted removal of pacemaker leads is regarded as the gold standard therapy for patients requiring pacing lead explantation. The Spectranetics Laser Sheath (SLS) is designed to allow safe and effective ablation of the fibrous tissue that binds pacing leads following implantation. The Spectranetics Lead Locking device (LLD) is a useful addition to the portfolio. This locking stylet is placed down the inner core of the pacing lead undergoing removal. The LLD is then deployed and grips the entire inner surface of the core, allowing traction. Applying traction to the device then allows removal of lead. Should the LLD need to be removed, the device is completely removable. Coronary applications Spectranetics offer a range of catheters to suit many interventional procedures. Most are ‘rapid exchange’ to allow compatibility with modern practice. The Excimer laser system has been widely used in coronary interventions to: · Debulk diffuse atherosclerotic disease. · Treat in-stent restenosis. · Cross chronic total occlusions. · Ablate fibrous tissue in undilatable lesions. · Ablate plaque within degenerated saphenous vein grafts. · Dissolve thrombus in patients with acute myocardial infarction. A comprehensive bibliography is available on request. Peripheral applications The success seen with laser revascularisation of coronary vessels has been translated to peripheral interventions. The Excimer laser has been approved for use in treating: · Long, diffuse lower limb arterial disease. · Critical limb ischaemia (CLI). · Acute thrombotic occlusions. · Chronic total occlusions. Recent studies in populations presenting with CLI have demonstrated excellent limb salvage rates in patients with significant co-morbidities and those unsuitable for surgical treatment. Further details on these and other studies can be found at www.spectranetics.com Valuation Trailing P/E (ttm, intraday): 47.80 Forward P/E (fye 31-Dec-09): 53.84 Ownership Shares Outstanding: 31.61M Float: 30.70M % Held by Insiders: 3.19% % Held by Institutions: 68.70% The CLiRpath System -- Vascular Surgery The Detroit News reports that Dearborn's Oakwood Hospital is one of few hospitals in the country to perform a procedure, called CLiRpath, for treatment of peripheral vascular disease. According to Spectranetics, the manufacturer of the laser system, the device has been FDA approved. Furthermore: Current alternatives to treat refractory total occlusions common in advanced arterial disease are limited, and "treatment" often is amputation. With a 95% limb salvage rate* among survivors, the new CLiRpath system gives your CLI patients with total occlusions not crossable by a guidewire, a viable alternative in the fight against amputation. Used in conjunction with the CVX-300® laser system, CLiRpath Extreme® Catheters use "cool" ultraviolet excimer laser energy to cross total obstructions and restore straightline blood flow to the foot, which may facilitate wound healing. The CVX-300 excimer laser is a pulsed system that vaporizes plaque and thrombus by delivering very high energy in extremely short pulses. The "cool" excimer laser ablates tissue on contact (about 50 microns from the catheter's tip) without inducing thermal damage to the treated artery. Debulking with CLiRpath prior to balloon angioplasty transforms total occlusions not crossable by a guidewire and diffuse multilevel disease into more easily ballooned stenoses. Great system, indeed. One of the most common methods to unblock thrombosed artery nowadays is to use a so-called Fogarty catheter (wire with an inflatable balloon at the tip), to surgically bypass the obstruction, or to amputate. One does not have to be a doctor to realize how sucky these options are. http://medgadget.com/archives/2005/01/
CHM Cannabis
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#37   1. SPNC has serious disclosure related issues including Leonitus 06/13/17 12:11:43 PM
#36   Amazing to see this near $30.00 still today.... I-Man 08/24/14 10:22:08 AM
#33   SPNC reminds me of REFG today and where I-Man 12/23/13 08:44:00 AM
#32   Just think, I first bought SPNC at 15 I-Man 11/19/13 04:24:16 PM
#31   very good post, MWM Terrence89 04/19/12 09:16:42 PM
#30   It is impressive technology nontheless Terrence89 04/19/12 09:16:12 PM
#29   does this company have new technology in developement? Terrence89 04/09/12 03:46:43 PM
#28   ~ Wednesday! $SPNC ~ Earnings posted, pending or Penny Roger$ 02/13/12 05:22:16 AM
#27   7:17AM On The Wires (WIRES) : surf1944 06/27/11 09:03:12 AM
#26   Spectranetics shares rise on analyst upgrade GuruTrader 10/26/09 11:34:23 AM
#25   Another medical device manufacturer worth looking into, as I-Man 02/25/09 09:53:45 AM
#24   Yeah I was one of the investors killed I-Man 12/17/08 09:27:33 AM
#23   WCG seems to have a had a very MWM 09/05/08 09:25:52 AM
#22   08:29 SPNC Spectranetics: News less ominous than speculation, MWM 09/05/08 09:13:07 AM
#21   Spectranetics Announces Federal Investigation MWM 09/04/08 11:17:16 PM
#20   SPNC Update MWM 09/04/08 03:37:46 PM
#19   Healthy outlook at laser company MWM 09/04/08 02:11:14 PM
#18   Spectranetics Announces First Laser Lead Extraction Procedures in Japan MWM 09/04/08 02:10:03 PM
#17   Crash MWM 09/04/08 02:00:15 PM
#16   Spectranetics, Medtronic settle intellectual property suit buhg1b 05/08/08 11:31:27 AM
#15   Yes, I also listen in on calls from buhg1b 04/24/08 02:00:06 PM
#14   No, I'm not a professional analyst and I Democritus_of_Abdera 04/24/08 01:48:13 PM
#13   Thanks for the input, much appreciated. Were buhg1b 04/24/08 01:15:22 PM
#12   Buhg1b, I was not as impressed with the Democritus_of_Abdera 04/24/08 01:00:22 PM
#11   Spectranetics, Q1 2008 Earnings Call Transcript buhg1b 04/24/08 10:31:04 AM
#10   Wednesday, April 9, 2008 buhg1b 04/24/08 10:29:38 AM
#9   22-Apr-08 Pacific Growth Equities Initiated Neutral buhg1b 04/24/08 10:28:56 AM
#8   Spectranetics First Quarter Revenue up 37% to $23.8 buhg1b 04/24/08 10:28:11 AM
#7   SPNC had two events this past week.... Democritus_of_Abdera 03/20/08 03:53:44 PM
#6   Declining Atherectomy Share of PAD Market... Democritus_of_Abdera 02/25/08 09:07:33 AM
#5   SPNC Strategy: Maximize Debt-Free Growth Democritus_of_Abdera 02/21/08 05:43:34 AM
#4   CSII as competitive threat to SPNC ... Democritus_of_Abdera 02/18/08 04:59:08 PM
#3   I know this stock and owned it once. I-Man 12/20/07 01:19:26 PM
#2   I opened a pos yesterday at 10.10. I konnikov 09/12/06 04:51:40 PM
#1   I opened a position in this stock at Hanahoe_PC 07/17/06 08:09:42 PM